Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DX25FY160
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $1,975
Award facts
- Contract value 100% obligated
- $1,975.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order, valued at $1,975.05, represents a child award under a larger indefinite delivery contract vehicle. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.9 billion prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, leverages this contract to supply critical pharmaceutical products and medical supplies to federal military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to deliver a diverse range of medications including specialty pharmaceuticals, brand-name and generic drugs, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. As a primary vendor supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, AmerisourceBergen operates under the DLA's Pharmaceutical Prime Vendor Global Program framework, which is structured to engage multiple regional contractors for enhanced supply chain resilience and comprehensive coverage of federal medical procurement requirements.
Quick answers
Who was awarded contract SPE2DX25FY160?
SPE2DX25FY160 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on August 18, 2025.
How much is contract SPE2DX25FY160 worth?
The government has obligated $1,975 on SPE2DX25FY160.
Is contract SPE2DX25FY160 an order under another contract?
Yes. SPE2DX25FY160 is a delivery order under SPE2DX17D4019, an indefinite delivery contract.
Was contract SPE2DX25FY160 competed?
The extent of competition for SPE2DX25FY160 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award